We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.

Cancer research | Oct 15, 2009

Phosphatase and tensin homologue (PTEN) loss and activation of the Akt-mammalian target of rapamycin (mTOR) pathway increases mRNA translation, increases levels of the antiapoptotic protein FLIP(S), and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in glioblastoma multiforme (GBM). In PTEN-deficient GBM cells, however, the FLIP(S) protein also exhibited a longer half-life than in PTEN mutant GBM cells, and this longer half-life correlated with decreased FLIP(S) polyubiquitination. FLIP(S) half-life in PTEN mutant GBM cells was reduced by exposure to an Akt inhibitor, but not to rapamycin, suggesting the existence of a previously undescribed, mTOR-independent linkage between PTEN and the ubiquitin-dependent control of protein stability. Total levels of the candidate FLIP(S) E3 ubiquitin ligase atrophin-interacting protein 4 (AIP4) were comparable in PTEN wild-type (WT) and PTEN mutant GBM cells, although in PTEN-deficient cells, AIP4 was maintained in a stable polyubiquitinated state that was less able to associate with FLIP(S) or with the FLIP(S)-containing death inducing signal complex. Small interfering RNA-mediated suppression of AIP4 levels in PTEN WT cells decreased FLIP(S) ubiquitination, prolonged FLIP(S) half-life, and increased TRAIL resistance. Similarly, the Akt activation that was previously shown to increase TRAIL resistance did not alter AIP4 levels, but increased AIP4 ubiquitination, increased FLIP(S) steady-state levels, and suppressed FLIP(S) ubiquitination. These results define the PTEN-Akt-AIP4 pathway as a key regulator of FLIP(S) ubiquitination, FLIP(S) stability, and TRAIL sensitivity and also define a novel link between PTEN and the ubiquitin-mediated control of protein stability.

Pubmed ID: 19808964 RIS Download

Mesh terms: Animals | Apoptosis | Blotting, Western | CASP8 and FADD-Like Apoptosis Regulating Protein | Cell Line, Tumor | Drug Resistance, Neoplasm | Glioblastoma | Half-Life | Humans | Immunoprecipitation | Mice | Mice, Knockout | PTEN Phosphohydrolase | Protein Kinases | Proto-Oncogene Proteins c-akt | RNA, Small Interfering | Repressor Proteins | Signal Transduction | Sirolimus | TNF-Related Apoptosis-Inducing Ligand | TOR Serine-Threonine Kinases | Ubiquitin | Ubiquitin-Protein Ligases | Ubiquitination | Xenograft Model Antitumor Assays

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: R01 CA115638
  • Agency: NCI NIH HHS, Id: R01 CA136774-04
  • Agency: NCI NIH HHS, Id: R01 CA115638-05
  • Agency: NCI NIH HHS, Id: CA136774
  • Agency: NCI NIH HHS, Id: P50 CA097257
  • Agency: NCI NIH HHS, Id: CA097257
  • Agency: NCI NIH HHS, Id: R01 CA136774
  • Agency: NCI NIH HHS, Id: CA115638

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.